Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure... see more

Recent & Breaking News (TSX:PRN)

Profound Medical Announces Second Quarter 2018 Financial Results

GlobeNewswire August 14, 2018

Profound Medical to Release Second Quarter 2018 Financial Results on August 14 – Conference Call to Follow

GlobeNewswire August 2, 2018

Profound Medical to Present at the Canaccord Genuity 38th Annual Growth Conference

GlobeNewswire July 31, 2018

Profound Medical Announces Term Loan Agreement with CIBC Innovation Banking

GlobeNewswire July 31, 2018

Profound Medical Corp. Announces Graduation to Toronto Stock Exchange

GlobeNewswire July 11, 2018

Profound Medical Announces Annual Meeting of Shareholders Voting Results; Welcomes Two Industry Veterans as Independent Directors to its Board

GlobeNewswire June 14, 2018

Profound Medical Corp. Announces First Quarter 2018 Financial Results

GlobeNewswire May 10, 2018

Profound Medical Corp. Announces Chinese Food and Drug Administration Approval for Sonalleve®

GlobeNewswire May 9, 2018

Profound Medical to Release First Quarter 2018 Financial Results on May 10, 2018 – Conference Call to Follow

GlobeNewswire May 2, 2018

Profound Medical Further Strengthens Management Team with Appointment of Aaron Davidson as Chief Financial Officer and Senior Vice-President of Corporate Development

GlobeNewswire May 1, 2018

Profound Medical Corp. Announces Fourth Quarter and Full Year 2017 Financial Results

GlobeNewswire March 26, 2018

Profound Medical Corp. Announces Closing of Bought Deal Financing

GlobeNewswire March 20, 2018

Profound Medical to Release Fourth Quarter and Full Year 2017 Financial Results on March 26, 2018 – Conference Call to Follow

GlobeNewswire March 9, 2018

Profound Medical Corp. Upsizes Previously Announced Bought Deal Financing

Canada NewsWire February 28, 2018

Profound Medical Corp. Announces $20 Million Bought Deal Financing

Canada NewsWire February 27, 2018

Profound Medical to Participate in 2018 BTIG Healthcare Conference

GlobeNewswire February 26, 2018

Profound Medical Corp. Announces Completion of Patient Enrollment in TACT Pivotal Clinical Trial  

GlobeNewswire January 31, 2018

Profound Medical Corp. Announces Preliminary Fourth Quarter 2017 Revenue and Provides Progress Update on TACT Pivotal Trial Patient Enrollment

GlobeNewswire January 8, 2018

Profound Medical Corp. to Present at the 29th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 14, 2017

Profound Medical Corp. Announces Third Quarter 2017 Financial Results

GlobeNewswire November 7, 2017